We are delivering: Quality, relevant research
- The National Health and Medical Research Council (NHMRC) awarded the Institute two major program grants for research into immunotherapy and tropical health, to be led by Mark Smyth and James McCarthy respectively.
- Our researchers achieved promising interim results in a Phase 1 clinical trial of an immunotherapy treatment for multiple sclerosis.
- We recruited a research group in health economics.
- We signed a research collaboration agreement with a US bio-pharmaceutical company to develop a new cancer treatment against a novel target identified by QIMR Berghofer researchers.
- We established a new start-up company, genomiQa, which will offer whole-genome analysis of cancer so treatments can be tailored to individual patients’ cancers. The company builds on Nic Waddell’s and John Pearson’s expertise in analysing genomic information.
- We provide biostatistics services to clinicians and researchers at Metro North HHS, Mater Medical Research Institute and Wesley Medical Research.
- Our papers were cited by researchers worldwide more than 38 000 times last year. This is the highest number of citations of any medical research institute in Australia.
We are delivering: Star researchers
- Nick Martin was named in the top 250 in a list of the most cited researchers of all time (Freud is number one).
- Michael Breakspear was awarded the Royal Australian and New Zealand College of Psychiatrists Senior Research Award.
- Mark Smyth was inducted into the Australian Academy of Science.
- Rajiv Khanna was appointed an Officer of the Order of Australia.
We are delivering: For the community, including regional queenslanders
- Our staff ran talks, workshops and educational activities in Gladstone and Chinchilla as part of World Science Festival Brisbane.
- In 2016-17, our researchers presented lectures to approximately 1100 high school students in Cairns, the Torres Strait, Townsville, Rockhampton and Toowoomba.
- In 2016-17, approximately 1500 high school students from across Queensland came to the Institute to spend a day in our education laboratory, to do work experience, to attend our high school lecture series, or for the World Science Festival Brisbane.
- We hosted a public forum on cancer immunotherapy as part of the Immunotherapy@Brisbane conference.
- Our Deputy Director, David Whiteman, appeared on ABC Radio Brisbane’s breakfast show once a week for six weeks to discuss major issues in health and medical research.
- Our staff have created a collection of scientific images, which have gone on display at the Queensland Museum as an exhibition called Tiny Worlds.
We are delivering: STRONG COLLABORATIONS
- We are active members and co-founders of the Brisbane Diamantina Health Partners, which was awarded certification as an Advanced Health and Translation Centre by the NHMRC.
- Five of our researchers were awarded grants by the Australian Skin and Skin Cancer Research Centre, which we co- founded with the University of Queensland.
- We are members of the Advance Queensland expert panel, the Advancing Health 2026 oversight committee, the board of the Australian Academy of Health and Medical Sciences, the Australian Association of Medical Research Institutes, the Herston Imaging Research Facility, the Australian Infectious Diseases Research Centre, the Queensland Tropical Health Alliance, and a number of other formal collaborations.
- We contribute expertise and analysis to state and federal government consultation processes, including the Senate Committee Hearing into Funding for Research into Cancers with Low Survival Rates, the Queensland Healthy Futures Commission, Research Guidelines for Aboriginal and Torres Strait Islander Research, and the Australian Code for the Responsible Conduct of Research.
We are delivering: ECONOMIC Benefits
- In 2016-17, we leveraged state government funding more than six-fold through competitive grants, commercial income and philanthropic donations.
- In 2016, QIMR Berghofer was the top-ranked medical research institute in Australia for obtaining funding from the NHMRC. We were sixth overall, including universities.
- We employ approximately 600 people and support another 120 students in their post-graduate studies.
- In line with State and Federal Government priorities, we have increased our efforts to generate revenue from our research. Our commercial income has grown from $1 million in 2011-12 to $20.4 million in 2016-17.
- We conduct collaborative and contract research involving 25 companies worldwide, which represents a significant expansion of trade and investment into Queensland and Australia.
Thanks to support from our donors and Queensland Health, as you can see, WE ARE DELIVERING.